• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cowen initiated coverage on AbCellera Biologics

    2/28/23 7:27:18 AM ET
    $ABCL
    Pharmaceuticals and Biotechnology
    Health Care
    Get the next $ABCL alert in real time by email
    Cowen initiated coverage of AbCellera Biologics with a rating of Outperform
    Get the next $ABCL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ABCL

    DatePrice TargetRatingAnalyst
    8/20/2024Buy → Hold
    The Benchmark Company
    2/22/2024$9.00Hold → Buy
    The Benchmark Company
    12/5/2023$6.00Overweight
    KeyBanc Capital Markets
    11/6/2023Buy → Hold
    The Benchmark Company
    10/13/2023$20.00Overweight
    Piper Sandler
    2/28/2023Outperform
    Cowen
    12/15/2022$30.00Buy
    Goldman
    11/16/2022$29.00Buy
    Truist
    More analyst ratings

    $ABCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Montalbano John S.

      4 - AbCellera Biologics Inc. (0001703057) (Issuer)

      6/16/25 5:32:00 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care
    • SEC Form 4 filed by Director Lo Andrew

      4 - AbCellera Biologics Inc. (0001703057) (Issuer)

      6/16/25 5:30:33 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care
    • Large owner Thermopylae Holdings Ltd. bought $742,243 worth of shares (343,631 units at $2.16), increasing direct ownership by 0.62% to 56,143,640 units (SEC Form 4)

      4 - AbCellera Biologics Inc. (0001703057) (Issuer)

      3/11/25 6:42:57 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care

    $ABCL
    SEC Filings

    See more
    • AbCellera Biologics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - AbCellera Biologics Inc. (0001703057) (Filer)

      6/13/25 1:20:33 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care
    • AbCellera Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - AbCellera Biologics Inc. (0001703057) (Filer)

      5/30/25 1:46:41 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care
    • AbCellera Biologics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - AbCellera Biologics Inc. (0001703057) (Filer)

      5/14/25 5:15:04 PM ET
      $ABCL
      Pharmaceuticals and Biotechnology
      Health Care